Center-Authored Papers

Filters: Author is Lucia, M Scott  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
V
Klein EA, Thompson IM, Tangen CM, Crowley J, Lucia SM, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano MJ et al..  2011.  Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).. JAMA : the journal of the American Medical Association. 306(14):1549-56. Abstract
Winchester DA, Till C, Goodman PJ, Tangen CM, Santella RM, Johnson-Pais TL, Leach RJ, Xu J, Zheng LS, Thompson IM et al..  2015.  Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.. The Prostate. Abstract
T
Goodman PJ, Tangen CM, Kristal AR, Thompson IM, Lucia SM, Platz EA, Figg WD, Hoque A, Hsing A, Neuhouser ML et al..  2010.  Transition of a clinical trial into translational research: the prostate cancer prevention trial experience.. Cancer prevention research (Philadelphia, Pa.). 3(12):1523-33. Abstract
S
Platz EA, Tangen CM, Goodman PJ, Till C, Parnes HL, Figg WD, Albanes D, Neuhouser ML, Klein EA, Lucia SM et al..  2014.  Statin Drug Use Is Not Associated with Prostate Cancer Risk in Men who are Regularly Screened.. The Journal of urology. Abstract
Nash SH, Till C, Song X, Lucia SM, Parnes HL, Thompson IM, Lippman SM, Platz EA, Schenk J.  2015.  Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(10):1507-1515. Abstract
P
Heaphy CM, Gaonkar G, Peskoe SB, Joshu CE, De Marzo AM, Lucia SM, Goodman PJ, Lippman SM, Thompson IM, Platz EA et al..  2015.  Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial.. The Prostate. 75(11):1160-6. Abstract
Thompson IM, Tangen CM, Lucia SM.  2008.  The Prostate Cancer Prevention Trial and the future of chemoprevention.. BJU international. 101(8):933-4.
Platz EA, Kulac I, Barber JR, Drake CG, Joshu CE, Nelson WG, Lucia SM, Klein EA, Lippman SM, Parnes HL et al..  2017.  A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Kulac I, Gumuskaya B, Drake CG, Gonzalez B, Arnold KB, Goodman PJ, Kristal AR, Lucia SM, Thompson IM, Isaacs WB et al..  2016.  Peripheral zone inflammation is not strongly associated with lower urinary tract symptom incidence and progression in the placebo arm of the prostate cancer prevention trial .. The Prostate. Abstract
Thompson IM, Tangen CM, Ankerst DP, Chi C, Lucia SM, Goodman P, Parnes H, Coltman CA.  2008.  The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsy.. The Journal of urology. 180(2):544-7. Abstract
L
Thompson IM, Goodman PJ, Tangen CM, Parnes HL, Minasian LM, Godley PA, Lucia SM, Ford LG.  2013.  Long-term survival of participants in the prostate cancer prevention trial.. The New England journal of medicine. 369(7):603-10. Abstract
K
Winchester DA, Gurel B, Till C, Goodman PJ, Tangen CM, Santella RM, Johnson-Pais TL, Leach RJ, Thompson IM, Xu J et al..  2016.  Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial.. The Prostate. 76(6):565-574. Abstract
I
Neuhouser ML, Platz EA, Till C, Tangen CM, Goodman PJ, Kristal A, Parnes HL, Tao Y, Figg WD, Lucia SM et al..  2013.  Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trial.. Cancer prevention research (Philadelphia, Pa.). 6(2):91-9. Abstract
Murtola T, Gurel B, Umbehr M, Lucia SM, Thompson IM, Goodman PJ, Kristal AR, Parnes HL, Lippman SM, Sutcliffe S et al..  2015.  Inflammation in benign prostate tissue and prostate cancer in the finasteride arm of the Prostate Cancer Prevention Trial.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
F
Song YJ, Tangen CM, Goodman P, Parnes HL, Lucia SM, Thompson IM, Kristal AR.  2008.  Finasteride, prostate cancer, and weight gain: evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatment.. The Prostate. 68(3):281-6. Abstract
Redman MW, Tangen CM, Goodman PJ, Lucia SM, Coltman CA, Thompson IM.  2008.  Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach.. Cancer prevention research (Philadelphia, Pa.). 1(3):174-81. Abstract
E
Lippman SM, Klein EA, Goodman PJ, Lucia SM, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano MJ, Hartline JA et al..  2009.  Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).. JAMA : the journal of the American Medical Association. 301(1):39-51. Abstract
D
Barrington WE, Schenk JM, Etzioni R, Arnold KB, Neuhouser ML, Thompson IM, Lucia SM, Kristal AR.  2015.  Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).. JAMA oncology. 1(3):342-9. Abstract
C
Gurel B, Lucia SM, Thompson IM, Goodman PJ, Tangen CM, Kristal AR, Parnes HL, Hoque A, Lippman SM, Sutcliffe S et al..  2014.  Chronic Inflammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Thompson IM, Tangen CM, Goodman PJ, Lucia SM, Klein EA.  2009.  Chemoprevention of prostate cancer.. The Journal of urology. 182(2):499-507;discussion508. Abstract
B
Tangen CM, Goodman PJ, Till C, Schenk JM, Lucia SM, Thompson IM.  2016.  Biases in Recommendations for and Acceptance of Prostate Biopsy Significantly Affect Assessment of Prostate Cancer Risk Factors: Results From Two Large Randomized Clinical Trials.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(36):4338-4344. Abstract
A
Winchester DA, Till C, Goodman PJ, Tangen CM, Santella RM, Johnson-Pais TL, Leach RJ, Xu J, Zheng LS, Thompson IM et al..  2017.  Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.. The Prostate. Abstract
Nash SH, Schenk JM, Kristal AR, Goodman PJ, Lucia SM, Parnes HL, Thompson IM, Lippman SM, Song X, Gurel B et al..  2015.  Association between serum phospholipid fatty acids and intraprostatic inflammation in the placebo arm of the Prostate Cancer Prevention Trial.. Cancer prevention research (Philadelphia, Pa.). Abstract
Figg WD, Chau CH, Price DK, Till C, Goodman PJ, Cho Y, Varella-Garcia M, Reichardt JKV, Tangen CM, Leach RJ et al..  2014.  Androgen Receptor CAG Repeat Length and TMPRSS2:ETS Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial.. Urology. Abstract
Thompson IM, Tangen CM, Paradelo J, Lucia SM, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G et al..  2009.  Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.. The Journal of urology. 181(3):956-62. Abstract